GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fredun Pharmaceuticals Ltd (BOM:539730) » Definitions » Shiller PE Ratio

Fredun Pharmaceuticals (BOM:539730) Shiller PE Ratio : 66.11 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Fredun Pharmaceuticals Shiller PE Ratio?

As of today (2024-05-27), Fredun Pharmaceuticals's current share price is ₹839.65. Fredun Pharmaceuticals's E10 for the quarter that ended in Mar. 2024 was ₹12.70. Fredun Pharmaceuticals's Shiller PE Ratio for today is 66.11.

The historical rank and industry rank for Fredun Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

BOM:539730' s Shiller PE Ratio Range Over the Past 10 Years
Min: 60.05   Med: 104.89   Max: 198.6
Current: 66.1

During the past years, Fredun Pharmaceuticals's highest Shiller PE Ratio was 198.60. The lowest was 60.05. And the median was 104.89.

BOM:539730's Shiller PE Ratio is ranked worse than
88.22% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.25 vs BOM:539730: 66.10

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fredun Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹10.850. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹12.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Fredun Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Fredun Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fredun Pharmaceuticals Shiller PE Ratio Chart

Fredun Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 142.36 85.17 56.47

Fredun Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.17 84.41 86.69 74.44 56.47

Competitive Comparison of Fredun Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Fredun Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fredun Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fredun Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fredun Pharmaceuticals's Shiller PE Ratio falls into.



Fredun Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fredun Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=839.65/12.7
=66.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fredun Pharmaceuticals's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Fredun Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.85/153.0345*153.0345
=10.850

Current CPI (Mar. 2024) = 153.0345.

Fredun Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.860 94.103 1.399
201409 0.341 96.780 0.539
201412 1.016 96.780 1.607
201503 -1.129 97.163 -1.778
201506 1.620 99.841 2.483
201509 0.070 101.753 0.105
201512 1.170 102.901 1.740
201603 1.640 102.518 2.448
201606 2.560 105.961 3.697
201609 1.394 105.961 2.013
201612 0.590 105.196 0.858
201703 1.820 105.196 2.648
201706 1.560 107.109 2.229
201709 1.470 109.021 2.063
201712 0.690 109.404 0.965
201803 2.130 109.786 2.969
201806 -1.838 111.317 -2.527
201809 5.640 115.142 7.496
201812 4.280 115.142 5.689
201903 3.210 118.202 4.156
201906 0.590 120.880 0.747
201909 2.200 123.175 2.733
201912 2.550 126.235 3.091
202003 -0.570 124.705 -0.699
202006 0.090 127.000 0.108
202009 2.070 130.118 2.435
202012 3.350 130.889 3.917
202103 -0.460 131.771 -0.534
202106 0.820 134.084 0.936
202109 4.610 135.847 5.193
202112 4.220 138.161 4.674
202203 5.130 138.822 5.655
202206 2.120 142.347 2.279
202209 7.110 144.661 7.522
202212 7.660 145.763 8.042
202303 6.200 146.865 6.460
202306 5.240 150.280 5.336
202309 8.400 151.492 8.486
202312 8.990 152.924 8.996
202403 10.850 153.035 10.850

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Fredun Pharmaceuticals  (BOM:539730) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Fredun Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Fredun Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fredun Pharmaceuticals (BOM:539730) Business Description

Traded in Other Exchanges
N/A
Address
Ganpatrao Kadam Marg, 11th Floor, Urmi Estate, Lower Parel (West), Mumbai, MH, IND, 400013
Fredun Pharmaceuticals Ltd is an India based company engaged in the business of pharmaceuticals and healthcare. The company manufactures pharmaceutical formulations, nutraceuticals, herbal supplements, and dietary supplements. In addition, it also manufactures animal healthcare products through its group companies. It sells its products in India and also exports its formulations as branded generics to international countries.

Fredun Pharmaceuticals (BOM:539730) Headlines

No Headlines